14 results
10-Q
2024 Q1
IMCR
Immunocore Holdings plc
8 May 24
Quarterly report
7:00am
a sustainable pipeline of new medicine candidates, including but not limited to future generations of KIMMTRAK and additional product candidates
DEF 14A
IMCR
Immunocore Holdings plc
12 Apr 24
Definitive proxy
4:20pm
executives at Immunocore are appropriately compensated and incentivised to deliver growth to shareholders in a long- term and sustainable manner … to deliver sustainable long-term growth and shareholder value.
While the Committee references US market practice as the primary benchmark for both
424B7
IMCR
Immunocore Holdings plc
5 Apr 24
Prospectus with selling stockholder info
4:34pm
of reaching patients in additional indications and territories;
our ability to build a sustainable pipeline of new product candidates, including … timing of reaching patients in additional indications and territories;
our ability to build a sustainable pipeline of new product candidates, including
PRE 14A
IMCR
Immunocore Holdings plc
2 Apr 24
Preliminary proxy
4:45pm
executives at Immunocore are appropriately compensated and incentivised to deliver growth to shareholders in a long- term and sustainable manner … sustainable long-term growth and shareholder value.
While the Committee references US market practice as the primary benchmark for both Executive
S-3ASR
IMCR
Immunocore Holdings plc
20 Mar 24
Automatic shelf registration
8:51pm
timing of reaching patients in additional indications and territories;
our ability to build a sustainable pipeline of new product candidates … for mUM, including expanding into and the related timing of reaching patients in additional indications and territories;
our ability to build a sustainable
8-K
EX-99.2
8gi2eui63h0aq
28 Feb 24
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
4:19pm
8-K
EX-99.1
q5clq8ox
28 Feb 24
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
4:19pm
10-K
a8e9ic1a argo2jpf58
28 Feb 24
Annual report
7:33am
8-K
EX-99.2
dlo1poap3w27syb6jto4
29 Jan 24
Immunocore Announces Proposed Convertible Senior Notes Offering
5:06pm
424B7
egp0n3bzt 1x
30 Sep 22
Prospectus with selling stockholder info
4:15pm
424B5
fcdgh
9 Sep 22
Prospectus supplement for primary offering
4:23pm
424B7
qitn9vgv hoo5wa
5 May 22
Prospectus with selling stockholder info
12:00am
F-3ASR
uwuieb2jl82e
4 Apr 22
Automatic shelf registration (foreign)
4:08pm
- Prev
- 1
- Next